Product Information

IMIPRAMINE HCL 50 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1528 per EA under NDC 64380017101. Its NADAC has been published 228 times since Jul 6, 2022.

FDA first approved this application on Oct 21, 1983. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IMIPRAMINE HCL 50 MG TABLET

Imipramine Hydrochloride
$0.1528per EA

Strength

50 mg/1

NDC

64380017101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

IMIPRAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA088276

FDA Approved

10/21/1983

TE Code

AB

On Market Since

4/11/2022

Pharmacological Classes

Price Statistics

The NADAC for IMIPRAMINE HCL 50 MG TABLET has been published 228 times since Jul 6, 2022, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1528 per EA
All-time high$0.1716 (Jul 13, 2022)
All-time low$0.0932 (Nov 20, 2024)
52-week high$0.1685
52-week low$0.1240
Median price$0.1330
Average price$0.1332
Largest weekly change+30.3% (Nov 22, 2023)
Weeks tracked228
Tracking sinceJul 6, 2022

Price History

1W

0.0%

1M

-1.8%

3M

+4.5%

6M

+20.7%

1Y

+17.2%

3Y

+53.2%

5Y

N/A

All

-10.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IMIPRAMINE HCL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IMIPRAMINE HCL 50 MG TABLET, manufactured by Strides Pharma Inc., is $0.1528 per EA (NDC 64380017101), effective Nov 11, 2026.

How has the price of IMIPRAMINE HCL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for IMIPRAMINE HCL 50 MG TABLET has declined 10.9%. It has been tracked across 228 weekly CMS publications since Jul 6, 2022.

What are the highest and lowest recorded NADAC prices for IMIPRAMINE HCL 50 MG TABLET?

Since Jul 6, 2022, the NADAC for IMIPRAMINE HCL 50 MG TABLET has ranged from a low of $0.0932 (Nov 20, 2024) to a high of $0.1716 (Jul 13, 2022), with a median of $0.1330 per EA.

Are there cheaper alternatives to IMIPRAMINE HCL 50 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IMIPRAMINE HCL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IMIPRAMINE HCL 50 MG TABLET?

IMIPRAMINE HCL 50 MG TABLET (NDC 64380017101) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.